What is Amgen's investing cash flow?

Amgen (AMGN) reported investing cash flow of -$716M in Q1 2026.

How has Amgen's investing cash flow changed year-over-year?

Amgen's investing cash flow decreased by 60.2% year-over-year, from -$447M to -$716M.

What is the long-term trend for Amgen's investing cash flow?

Over 2 years (2022 to 2025), Amgen's investing cash flow has grown at a -43.3% compound annual growth rate (CAGR), from -$6.04B to -$1.94B.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Amgen AMGN Investing Cash Flow

Investing Cash Flow at other companies

Eli LillyLLY

-$3.92B-16.8%

PfizerPFE

$785M-76.0%

Regeneron PharmaceuticalsREGN

-$428.9M-166%

Nektar TherapeuticsNKTR

-$350.79M-903%

Oruka Therapeutics, Inc.ORKA

-$14.44M-134%

Rigel PharmaceuticalsRIGL

-$7.98M+24.4%

Other financials

Income statement

See full

Revenue$8.6B+5.8%

Gross profit$5.9B+13.4%

Operating income$2.7B+126%

Net income$1.8B+5.1%

EPS (diluted)$3.34+4.4%

Balance sheet

See full

Cash & equivalents$559.0M+10.0%

Total debt$57.3B-0.1%

Total equity$9.2B+48.1%

Total assets$92.5B+3.5%

Cash flow

See full

Operating cash flow$2.2B+57.4%

CapEx$712.0M+73.2%

Free cash flow$1.5B+50.7%

Valuation

See full

Market cap$195.44B+34.6%

Enterprise value$252.2B+25.7%

P/E25.1×+3.1×

P/S5.3×+1.1×

Profitability

See full

Gross margin68.3%+5.3pp

Operating margin28.4%+6.6pp

Net margin21%+3.6pp

FCF margin23.1%-8.9pp

Returns & leverage

See full

Return on equity101.3%-4.4pp

Debt / equity6.2×-3.0×

Current ratio1.3×+0.1×

Where this comes from

Reported directly by Amgen in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Amgen’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amgen's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Amgen's investing cash flow?: Amgen (AMGN) reported investing cash flow of -$716M in Q1 2026.
How has Amgen's investing cash flow changed year-over-year?: Amgen's investing cash flow decreased by 60.2% year-over-year, from -$447M to -$716M.
What is the long-term trend for Amgen's investing cash flow?: Over 2 years (2022 to 2025), Amgen's investing cash flow has grown at a -43.3% compound annual growth rate (CAGR), from -$6.04B to -$1.94B.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.